Evaluating automated longitudinal tumor measurements for glioblastoma response assessment
Loading...
Author (Corporation)
Publication date
2023
Type of student thesis
Course of study
Collections
Type
01A - Journal article
Editors
Editor (Corporation)
Supervisor
Parent work
Frontiers in Radiology
Special issue
DOI of the original publication
Link
Series
Series number
Volume
3
Issue / Number
Pages / Duration
Patent number
Publisher / Publishing institution
Frontiers
Place of publication / Event location
Edition
Version
Programming language
Assignee
Practice partner / Client
Abstract
Automated tumor segmentation tools for glioblastoma show promising performance. To apply these tools for automated response assessment, longitudinal segmentation, and tumor measurement, consistency is critical. This study aimed to determine whether BraTumIA and HD-GLIO are suited for this task. We evaluated two segmentation tools with respect to automated response assessment on the single-center retrospective LUMIERE dataset with 80 patients and a total of 502 post-operative time points. Volumetry and automated bi-dimensional measurements were compared with expert measurements following the Response Assessment in Neuro-Oncology (RANO) guidelines. The longitudinal trend agreement between the expert and methods was evaluated, and the RANO progression thresholds were tested against the expert-derived time-to-progression (TTP). The TTP and overall survival (OS) correlation was used to check the progression thresholds. We evaluated the automated detection and influence of non-measurable lesions. The tumor volume trend agreement calculated between segmentation volumes and the expert bi-dimensional measurements was high (HD-GLIO: 81.1%, BraTumIA: 79.7%). BraTumIA achieved the closest match to the expert TTP using the recommended RANO progression threshold. HD-GLIO-derived tumor volumes reached the highest correlation between TTP and OS (0.55). Both tools failed at an accurate lesion count across time. Manual false-positive removal and restricting to a maximum number of measurable lesions had no beneficial effect. Expert supervision and manual corrections are still necessary when applying the tested automated segmentation tools for automated response assessment. The longitudinal consistency of current segmentation tools needs further improvement. Validation of volumetric and bi-dimensional progression thresholds with multi-center studies is required to move toward volumetry-based response assessment.
Keywords
glioblastoma, segmentation, automated response assessment, RANO, tumor burden measurements, longitudinal
Subject (DDC)
Event
Exhibition start date
Exhibition end date
Conference start date
Conference end date
Date of the last check
ISBN
ISSN
2673-8740
Language
English
Created during FHNW affiliation
No
Strategic action fields FHNW
Publication status
Published
Review
Peer review of the complete publication
Open access category
Gold
Citation
Suter, Y., Notter, M., Meier, R., Loosli, T., Schucht, P., Wiest, R., Reyes, M., & Knecht, U. (2023). Evaluating automated longitudinal tumor measurements for glioblastoma response assessment. Frontiers in Radiology, 3. https://doi.org/10.3389/fradi.2023.1211859